Acetylcysteinamide for dementia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Apr 2024: Trial started, NCT07716865
  2. 21 Jul 2026: Trial registered, NCT07716865

The trials

NCT07716865: Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)

State
Under way
Phase
Phase 2
People
15 taking part
Started
3 Apr 2024
Primary completion
29 Dec 2026
Arms
Landspitali University Hospital
Results
None posted
  1. 3 Apr 2024: Trial started
  2. 21 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Naca.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.